The London Stock Exchange saw its largest delisting wave since 2009 in 2024, with 88 companies exiting amid liquidity ...

The all-share merger – which, if completed, would see Poolbeg de-list from the London Stock Exchange's AIM – would create a "strong clinical-stage biopharmaceutical company focused on ...

Businessman Cathal Friel’s Poolbeg Pharma is exploring a possible merger that would see the business shift its listing to the ...

The London Stock Exchange (LSE) saw the largest outflow of companies since the global financial crisis during last year, ...

US biopharmaceuticals giant Gilead has thrown its weight behind a potential merger of Ireland’s Poolbeg Pharma and Austria ...

A ‘lack of enthusiasm’ for London’s top stock market index nevertheless meant it lagged behind its US rival for another year, ...

The all-share merger – which if completed would see Poolbeg de-list from the London Stock Exchange's AIM – would create a "strong clinical-stage biopharmaceutical company focused on developing and ...

As the week progresses, eyes turn to US jobs data, with a host of readings culminating with Friday's nonfarm payrolls. "We get our first major market event of the calendar year on Friday, when nonfarm ...

He wants to replace Lina Khan, the agency's commissioner, with Andrew Ferguson, who is expected to be less aggressive in blocking large mergers. The London Stock Exchange Group predicted that ...

The latter flags that “the more affordable markets in the north” will experience the strongest house price growth in the ...

in early morning trading on Friday on the London Stock Exchange — a three-year low — having dropped 13.7% to $3.15 on the New York Stock Exchange at the close of play on Thursday. Holders of ...

These new shares are expected to be admitted to the Official List and commence trading on the London Stock Exchange (LON:LSEG) on December 20, 2024. Following the mergers, there have been changes ...